Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS
Authors:
- Jacques ReynesJRJacques Reynes
- Edouard TuaillonETEdouard Tuaillon
- Pierre-Alain RubboPRPierre-Alain Rubbo
- Olivier LortholaryOLOlivier Lortholary
- Brigitte MontesBMBrigitte Montes
- Vincent Le MoingVMVincent Le Moing
- Alain MakinsonAMAlain Makinson
- 23 October 2012
- journal article
- case report
- Published by Wolters Kluwer Health in AIDS
- Vol. 26 (16) , 2110-2112
Abstract
Management of relapsing or refractory immune reconstitution inflammatory syndromes (IRISs) despite corticosteroid therapy is yet to be defined. We describe three HIV-infected patients with corticosteroid-dependent and life-threatening paradoxical immune reconstitution inflammatory syndrome for whom thalidomide treatment induced rapid clinical remission and permitted complete corticosteroid withdrawal without clinical relapse.Keywords
This publication has 12 references indexed in Scilit:
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsThe Lancet Infectious Diseases, 2010
- Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndromeAIDS, 2010
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Treatment of HIV‐Related Inflammatory Cerebral Cryptococcoma with AdalimumabClinical Infectious Diseases, 2010
- Immunopathogenesis and Diagnosis of Tuberculosis and Tuberculosis‐Associated Immune Reconstitution Inflammatory Syndrome during Early Antiretroviral TherapyThe Journal of Infectious Diseases, 2009
- Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph NodesClinical Infectious Diseases, 2008
- Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in FranceAIDS, 2005
- Adjunctive Thalidomide Therapy for Childhood Tuberculous Meningitis: Results of a Randomized StudyJournal of Child Neurology, 2004
- Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1997
- Thalidomide Inhibits Tumor Necrosis Factor- Production by Lipopolysaccharide- and Lipoarabinomannan-Stimulated Human Microglial CellsThe Journal of Infectious Diseases, 1995